BrainSpec is an AI powered software platform that provides the first of its kind virtual biopsy. We measure brain chemistry to create disease specific chemical fingerprints in conditions such as brain tumors, Alzheimer's disease, epilepsy, and multiple sclerosis. We recently received Breakthrough Designation with the FDA and have Pilot Sites at Penn, MD Anderson, Boston Children's Hospital and Mass General.
Is this your company?
Something looks off?